In “Acknowledgments” on page 3188, National Heart, Lung, and Blood Institute (NHLBI) grant OT3HL147741 should not have been cited. The error has been corrected in the published article.
© 2021 by The American Society of Hematology
2021
ERRATUM|
July 9, 2021
Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
Blood Adv (2021) 5 (13): 2752.
